Pharvaris B.V. (PHVS) PT Raised to $79 at Citizens on Agent Trial Success

September 9, 2026 4:12 AM

Citizens analyst Jonathan Wolleben raised the price target on Pharvaris B.V. (NASDAQ: PHVS) to $79.00 (from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found